Funding for this research was provided by:
Novartis Pharmaceuticals Corporation (HEORUSV201137)
National Center for Advancing Translational Sciences (UL1TR000161)
Received: 7 March 2021
Accepted: 1 December 2021
First Online: 20 December 2021
: All procedures in this study were conducted in accordance with the UMass Medical School Institutional Review Board (H00019354, H00016873).
: The UMass Medical School Institutional Review Board (H00019354, H00016873) provided a waiver of written consent. Informed consent was obtained from participants in the form of a Fact Sheet containing elements of written consent.
: Authors Lapane, Liu, Dube, Ferrucci, Kay, Khan, and Kuhn have no conflicts. Dr. Yi is an employee of Novartis.